Stephens Inc Bioventus Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Stephens Inc holds 55,700 shares of BVS stock, worth $683,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares

55,700

Previous 84,025 33.71%

Holding current value

$683,439

Previous $483,000 37.68%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$5.73 - $11.95 $162,302 - $338,483	-28,325 Reduced 33.71%	55,700 $665,000
Q2 2024 Aug 06, 2024	SELL	$3.96 - $6.93 $125,928 - $220,374	-31,800 Reduced 27.46%	84,025 $483,000
Q1 2024 May 15, 2024	SELL	$4.33 - $5.75 $116,260 - $154,387	-26,850 Reduced 18.82%	115,825 $602,000
Q4 2023 Feb 13, 2024	SELL	$2.89 - $5.34 $25,432 - $46,992	-8,800 Reduced 5.81%	142,675 $751,000
Q3 2023 Nov 14, 2023	SELL	$2.8 - $4.94 $339,138 - $598,337	-121,121 Reduced 44.43%	151,475 $499,000
Q2 2023 Aug 14, 2023	SELL	$0.93 - $3.64 $34,619 - $135,499	-37,225 Reduced 12.02%	272,596 $787,000
Q1 2023 May 15, 2023	SELL	$1.07 - $2.95 $31,677 - $87,334	-29,605 Reduced 8.72%	309,821 $331,000
Q4 2022 Jan 25, 2023	SELL	$1.81 - $8.14 $43,847 - $197,191	-24,225 Reduced 6.66%	339,426 $886,000
Q3 2022 Nov 02, 2022	BUY	$6.54 - $9.08 $148,785 - $206,570	22,750 Added 6.67%	363,651 $2.55 Million
Q2 2022 Aug 03, 2022	BUY	$6.82 - $13.82 $726,705 - $1.47 Million	106,555 Added 45.47%	340,901 $2.33 Million
Q1 2022 May 04, 2022	BUY	$11.65 - $15.28 $579,704 - $760,332	49,760 Added 26.96%	234,346 $3.3 Million
Q4 2021 Mar 07, 2022	BUY	$12.37 - $16.77 $2.28 Million - $3.1 Million	184,586 New	184,586 $2.68 Million

Others Institutions Holding BVS

# of Institutions

142

Shares Held

45.9M

Call Options Held

179K

Put Options Held

124K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $757M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account